[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345855-105":59,"doc-detail-345855-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","loss-of-kmt2cd-promotes-gastric-cancer-and-confers-vulnerability-to-mtorc1-and-pd-1-inhibition","Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD-1 inhibition","","Kmt2c/d loss-of-function mutations are enriched and co-occur in gastric adenocarcinoma, prompting the development of genetically engineered mouse models with conditional knockout in gastric epithelial cells. Kmt2c/d loss causes nuclear dysplasia and aberrant lineage marker expansion, and accelerates muscle-invasive adenocarcinoma when combined with Pten deletion. Single-cell RNA-seq integration shows coordinated clustering of normal and cancerous epithelial states. Mechanistically, knockout reduces protein synthesis, increases ribosomal protein transcription, and heightens sensitivity to mTORC1 inhibitors, alongside enhanced antigen presentation. Combined mTORC1 inhibition and PD-1 blockade markedly suppress tumor growth in immune-competent mice.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/loss-of-kmt2cd-promotes-gastric-cancer-and-confers-vulnerability-to-mtorc1-and-pd-1-inhibition/345855/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/loss-of-kmt2cd-promotes-gastric-cancer-and-confers-vulnerability-to-mtorc1-and-pd-1-inhibition/345855.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were Kmt2c and Kmt2d functions tested in the study?","Question",{"text":112,"@type":113},"The study used genetically engineered mouse models with conditional knockout of Kmt2c and Kmt2d in gastric epithelial cells using Cre-mediated gene deletion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What phenotypes and tumor outcomes did Kmt2c/d loss produce?",{"text":117,"@type":113},"Kmt2c/d loss led to nuclear dysplasia and expansion of cells with mixed gastric lineage markers, and when combined with Pten deletion it drove rapid development of muscle-invasive gastric adenocarcinoma.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is the tumor sensitive to mTORC1 and PD-1 inhibition?",{"text":121,"@type":113},"Kmt2c/d knockout reduced protein synthesis while upregulating ribosomal protein transcription, producing hypersensitivity to mTORC1 inhibitors, and it increased MHC class I expression and antigen presentation. The combination of mTORC1 inhibition and anti–PD-1 immunotherapy suppressed tumor growth in immune-competent mice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345855,1790175597,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nLoss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD-1 inhibition  \nNaitao Wang,1,2 Dan Li,2 Tao Zhang,2 Mohini R. Pachai,2 Dana M. Schoeps,2 Yudi Bao,2,3 Woo Hyun Cho,2 Makhzuna N. Khudoynazarova,2 Kae Kristoff,2 Marion Liu,2,4 Laura Tang,5 Yelena Y. Janjigian,6,7 Ping Chi,2,6,7 and Yu Chen2,6,7  \n1Shenzhen University Medical School, Shenzhen, China. 2Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 3Peking University People’s Hospital, Beijing, China. 4Department of Surgery, 5Department of Pathology, and 6Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 7Department of Medicine, Weill Cornell Medical College, New York, New York, USA.  \nBased on the observation that loss-of-function mutations of KMT2Cand KMT2D (KMT2C/D) are enriched and co-occur in gastric adenocarcinoma, we developed genetically engineered mouse models (GEMMs) to conditionally knock out Kmt2c and Kmt2d in gastric epithelial cells. We observed that Kmt2c/d loss led to nuclear dysplasia, cellular crowding, and expansion of cells with mixed gastric lineage markers. When combined with Pten deletion, Kmt2c/d loss drove rapid development of muscle-invasive gastric adenocarcinoma as early as 3 weeks after Cre-mediated gene deletion. The adenocarcinoma exhibited decreased expression of gastric lineage markers and increased expression of intestinal differentiation markers, phenocopying human intestinal-type gastric adenocarcinoma. Bioinformatic integration of single-cell RNA-seq of our GEMMs and human gastric cancer datasets showed coclustering of normal and of cancerous gastric epithelial cells. Kmt2c/d knockout in gastric epithelium reduced protein synthesis but upregulated transcription of ribosomal proteins, rendering the cells hypersensitive to mTOR complex 1 (mTORC1) inhibitors. Additionally, Kmt2c/d knockout increased MHC class I molecule expression and enhanced antigen presentation. Combination of mTORC1 inhibition and anti–programmed cell death 1 immunotherapy markedly suppressed tumor growth in immune-competent mice. Together, these findings reveal the role of Kmt2c/d loss in gastric cancer initiation and suggest potential therapeutic strategies for KMT2C/D-deficient gastric cancer.  \nIntroduction  \nGastric or stomach adenocarcinoma (STAD) is the fifth most common cancer and the fourth most common cause of cancer death worldwide (1) . Gastric cancer exhibits histological and molecular heterogeneity, correlating with diverse genetic mutations and clinical outcomes (2) . Based on molecular profiles, STAD can be classified into 4 major subtypes: microsatellite instability (MSI), EpsteinBarr virus–positive (EBV), genomically stable (GS), and chromatin instability (CIN) (3, 4) . Histologically, MSI, EBV, and CIN tumors are enriched for intestinal subtype and GS tumors for diffuse subtype (5) . Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) hotspot mutations are the most prevalent in EBV subtype, loss of cadherin 1 is the dominant mutation in GS subtype, and TP53 loss-of-function (LOF) mutations are the leading alteration in CIN subtype. While dysfunction of the mismatch repair (MMR) system is the primary cause of hypermutagenesisin MSI subgroup, the drivers of cancer initiation in this subtype remain largely unexplored. In the MSI subgroup, mutations in the  \nRelated Commentary: [https://doi.org/10.1172/JCI208392](https://doi.org/10.1172/JCI208392)  \nAuthorship note: NW, DL, and TZ contributed equally to this work.  \nCopyright: © 2026, Wang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nSubmitted: April 14, 2025; Accepted: May 8, 2026; Published: May 12, 2026.  \nReference information: J Clin Invest. 2026;136(14):e194462 .  \n[https://doi.org/10.1172/JCI194462](https://d","cbCaiq65PtajIp8T","https://ap.wps.com/l/cbCaiq65PtajIp8T","pdf",29284537,"English","# Introduction\n## Gastric adenocarcinoma subtypes and molecular heterogeneity\n## KMT2C/KMT2D function and relevance to tumorigenesis\n## Immunotherapy context for KMT2C/D alterations","[{\"question\":\"How were Kmt2c and Kmt2d functions tested in the study?\",\"answer\":\"The study used genetically engineered mouse models with conditional knockout of Kmt2c and Kmt2d in gastric epithelial cells using Cre-mediated gene deletion.\"},{\"question\":\"What phenotypes and tumor outcomes did Kmt2c/d loss produce?\",\"answer\":\"Kmt2c/d loss led to nuclear dysplasia and expansion of cells with mixed gastric lineage markers, and when combined with Pten deletion it drove rapid development of muscle-invasive gastric adenocarcinoma.\"},{\"question\":\"Why is the tumor sensitive to mTORC1 and PD-1 inhibition?\",\"answer\":\"Kmt2c/d knockout reduced protein synthesis while upregulating ribosomal protein transcription, producing hypersensitivity to mTORC1 inhibitors, and it increased MHC class I expression and antigen presentation. The combination of mTORC1 inhibition and anti–PD-1 immunotherapy suppressed tumor growth in immune-competent mice.\"}]","Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD-1 inhibition | PDF",1790059134,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89bcb36e7e6b81cd677ab277a3d24f3c.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5ceaf4d9aa3668fd82121040d68c62d.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b50937f5aa27bdf25b57c705b3a8630d.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/080c8126287a3891cb8f3c917b29fdf5.webp",980,1311]